Abstract:Objective Unplanned invasive mechanical ventilation (IMV) is associated with high mortality in lung cancer patients. We aimed to identify factors associated with weaning from IMV, intensive care unit (ICU) survival and 1-year survival in lung cancer patients requiring unplanned IMV. Design Retrospective observational study (2007–2017). Setting University-affiliated ICU. Patients Lung cancer patients requiring unplanned IMV. Intervention None. Main variables of interest Weaning from IMV, ICU and 1-year survival. Results Of the 136 patients included in the analysis (age 64 (9) years, male 110 (81%), metastatic disease 97 (62%)), 52 (38%) were weaned from IMV, 51 (38%) were discharged from ICU and 22 (16%) were alive at 1 year. The main indication for intubation was acute respiratory failure. In multivariate analysis, PaO 2 /FiO 2 >175 mmHg at ICU admission and intubation before ICU admission were associated with successful weaning from IMV while intubation for cardiac arrest was associated with weaning failure. Same factors were associated with ICU survival. Absence of metastasis at ICU admission and lung resection surgery were independently associated with 1-year survival. Conclusions A significant proportion of patients with lung cancer treated with unplanned IMV could be weaned from IMV and survived to ICU discharge, especially in the absence of severe hypoxemia at ICU admission. The low one-year survival was mostly driven by metastatic status. Resumen Objetivo La ventilación mecánica invasiva (VMI) no planificada se asocia a una elevada mortalidad en pacientes con cáncer de pulmón. El objetivo de nuestro estudio fue identificar los factores asociados con el destete de la VMI y la supervivencia en unidad de cuidados intensivos (UCI) y a 1 año en pacientes con cáncer de pulmón que requieren VMI no planificada. Diseño Estudio observacional retrospectivo (2007–2017). Ámbito UCI universitaria. Pacientes Pacientes con cáncer de pulmón que requirieron VMI no planificada. Intervención Ninguna. Variables de interés principales Destete de la VMI y supervivencia a 1 año. Resultados Se incluyeron 136 pacientes: edad 64(9) años, sexo masculino 110 (81%), enfermedad metastásica 97 (62%). De ellos, 52 (38%) fueron destetados de la VMI. La supervivencia en UCI y al año era 38% (n = 51) y 16% (n = 22) respectivamente. La principal indicación de intubación fue la insuficiencia respiratoria aguda. En el análisis multivariante, la PaO 2 /FiO 2 >175 mmHg al ingreso en la UCI y la intubación realizada antes del ingreso en la UCI se asociaron a un destete satisfactorio de la VMI, mientras que la intubación por parada cardiaca se asoció a un fracaso del destete. Los mismos factores se encontraron para la supervivencia en UCI. La ausencia de metástasis al ingreso en la UCI y la cirugía de resección pulmonar se asociaron de forma independiente con la supervivencia a 1 año. Conclusiones Una proporción significativa de pacientes con cáncer de pulmón tratados con VMI no planificada pueden ser destetados de la VMI, especialmente en ausencia de hipoxemia grave al ingreso en UCI. La baja supervivencia a un año se debió principalmente al estado metastásico.

Prognosis of Lung Cancer Patients With Life-Threatening Complications

Characteristics and Clinical Outcomes of Patients with Lung Cancer Requiring ICU Admission: a Retrospective Analysis Based on the MIMIC-III Database

Characteristics, management, and outcomes of patients with lung cancer admitted to a tertiary care intensive care unit over more than 20 years

Short- and Medium-Term Survival of Critically Ill Patients with Solid Cancer Admitted to the Intensive Care Unit

Outcomes in critically ill cancer patients with septic shock of pulmonary origin

Survival among patients with lung cancer managed at a tertiary care center in North India

Significant Clinical Factors Associated with Long-term Mortality in Critical Cancer Patients Requiring Prolonged Mechanical Ventilation

Improved survival of cancer patients admitted to the ICU between 2002 and 2011 at a U.S. teaching hospital

Treatment of Lung Cancer Patients With Actionable Mutations in the Intensive Care Unit

A definitive prognostication system for patients with thoracic malignancies diagnosed with COVID-19: an update from the TERAVOLT registry.

Clinical Outcomes and Determinants of Survival in Patients with Hematologic Malignancies Admitted to Intensive Care Units with Critical Illness

Risk Factors And Prognosis Of Critically Ill Cancer Patients With Postoperative Acute Respiratory Insufficiency

COVID-19 among lung cancer patients: data from a real-life prospective French multicentric study

In-hospital Mortality of lung Cancer Higher than Non-cancerous Critically ill Patients following ICU discharge: A propensity match Analysis

Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies

Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia

Early Complications in Surgical Treatment of Lung Cancer: A Prospective, Multicenter Study

Prognosis of COPD Patients Admitted to the ICU in Middle Income Countries

Prognostic and risk factor analysis of cancer patients after unplanned ICU admission: a real-world multicenter study

Factors associated with short- and long-term outcomes in lung cancer patients requiring unplanned invasive mechanical ventilation

Cancer inpatients with COVID-19: A report from the Brazilian National Cancer Institute